Home >> Signaling Pathways >> Apoptosis

Apoptosis

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

What is Apoptosis? The Apoptotic Pathways and the Caspase Cascade

Targets for  Apoptosis

Products for  Apoptosis

  1. Cat.No. Product Name Information
  2. GC33356 AM-8735 AM-8735 is a potent and selective MDM2 inhibitor with an IC50 of 25 nM. AM-8735  Chemical Structure
  3. GC42776 Amarogentin

    A secoiridoid glycoside with diverse biological activities

    Amarogentin  Chemical Structure
  4. GN10484 Amentoflavone

    Didemethyl Ginkgetin, NSC 295677

    Amentoflavone  Chemical Structure
  5. GC42783 Ametantrone

    NSC 196473, NSC 290813

    Ametantrone (NSC 196473) is an antitumor agent that intercalates into DNA and induces topoisomerase II (TOP2)-mediated DNA break. Ametantrone  Chemical Structure
  6. GC19452 AMG-176

    AMG-176

    AMG-176 (Tapotoclax) is a potent, selective and orally active MCL-1 inhibitor, with a Ki of 0.13 nM.  AMG-176  Chemical Structure
  7. GC15828 AMG232

    AMG 232;AMG-232

    AMG232 (AMG 232) is a potent, selective and orally available inhibitor of p53-MDM2 interaction, with an IC50 of 0.6 nM. AMG232 binds to MDM2 with a Kd of 0.045 nM. AMG232  Chemical Structure
  8. GC42785 Amifostine (hydrate)

    Ethyol, WR 2721

    Amifostine (hydrate) (WR2721 trihydrate) is a broad-spectrum cytoprotective agent and a radioprotector. Amifostine (hydrate) selectively protects normal tissues from damage caused by radiation and chemotherapy. Amifostine (hydrate) is potent hypoxia-inducible factor-α1 (HIF-α1) and p53 inducer. Amifostine (hydrate) protects cells from damage by scavenging oxygen-derived free radicals. Amifostine (hydrate) reduces renal toxicity and has antiangiogenic action. Amifostine (hydrate)  Chemical Structure
  9. GC61804 Amifostine thiol Amifostine thiol (WR-1065) is an active metabolite of the cytoprotector Amifostine. Amifostine thiol is a cytoprotective agent with radioprotective abilities. Amifostine thiol activates p53 through a JNK-dependent signaling pathway. Amifostine thiol  Chemical Structure
  10. GC12051 Amiloride HCl dihydrate Amiloride HCl dihydrate (MK-870 hydrochloride dihydrate) is an inhibitor of both epithelial sodium channel (ENaC[1]) and urokinase-type plasminogen activator receptor (uTPA[2]). Amiloride HCl dihydrate  Chemical Structure
  11. GC63932 Amsilarotene Amsilarotene (TAC-101; Am 555S), an orally active synthetic retinoid, has selective affinity for retinoic acid receptor α (RAR-α) binding with Ki of 2.4, 400 nM for RAR-α and RAR-β. Amsilarotene induces the apoptotic of human gastric cancer, hepatocellular carcinoma and ovarian carcinoma cells. Amsilarotene can be used for the research of cancer. Amsilarotene  Chemical Structure
  12. GC16391 Amuvatinib (MP-470, HPK 56)

    HPK56, MP470

    A multi-targeted RTK inhibitor Amuvatinib (MP-470, HPK 56)  Chemical Structure
  13. GC91088 AMX12006

    An EP4 receptor antagonist

    AMX12006  Chemical Structure
  14. GC48339 Amycolatopsin A A macrolide polyketide with antimycobacterial and anticancer activities Amycolatopsin A  Chemical Structure
  15. GC48341 Amycolatopsin B A bacterial metabolite Amycolatopsin B  Chemical Structure
  16. GC48350 Amycolatopsin C A polyketide macrolide with antimycobacterial and anticancer activities Amycolatopsin C  Chemical Structure
  17. GC42806 Andrastin A

    NSC 697452

    Andrastin A is a meroterpenoid farnesyltransferase inhibitor. Andrastin A  Chemical Structure
  18. GN10045 Angelicin

    Bakuchicin, NSC 404563

    Angelicin  Chemical Structure
  19. GC60584 Angiotensin II human acetate

    Angiotensin II human (Angiotensin II) acetate is a vasoconstrictor and a major bioactive peptide of the renin/angiotensin system.

    Angiotensin II human acetate  Chemical Structure
  20. GC42813 Anguinomycin A

    5-Demethylleptomycin A

    Anguinomycin A is an antibiotic first isolated from a Streptomyces sp. Anguinomycin A  Chemical Structure
  21. GC40614 Anhydroepiophiobolin A

    3-Anhydro-6-epi-ophiobolin A

    Anhydroepiophiobolin A, an analog of Ophiobolin A, is a potent inhibitor of photosynthesis (I50s of 6.1 and 1 mM for photosynthesis in Chlorella and Spinach, respectively). Anhydroepiophiobolin A  Chemical Structure
  22. GC40214 Anhydroophiobolin A

    Anhydrocochliobolin A, 3-Anhydroophiobolin A

    Anhydroophiobolin A is an ophiobolin fungal metabolite that has been found in C. Anhydroophiobolin A  Chemical Structure
  23. GC11559 Anisomycin

    Flagecidin, NSC 76712, Wuningmeisu C

    Anisomycin, an antibiotic isolated from Streptomyces griseus, is also a JNK activator. Anisomycin  Chemical Structure
  24. GC49259 Antagonist G (trifluoroacetate salt)

    Arg-D-Trp-NmePhe-D-Trp-Leu-Met-NH2, Arg6,D-Trp7,9,NmePhe8-substance P (6-11)

    A neuropeptide antagonist Antagonist G (trifluoroacetate salt)  Chemical Structure
  25. GC73309 Anti-melanoma agent 1 Anti-melanoma agent 1 (Compound 5m) is an anti-melanoma agent and induces cell apoptosis. Anti-melanoma agent 1  Chemical Structure
  26. GC72337 Anti-Mouse 4-1BB/CD137 Antibody (3H3) Anti-Mouse 4-1BB/CD137 Antibody (3H3) is an anti-mouse 4-1BB IgG2a antibody inhibitor derived from the host Rat. Anti-Mouse 4-1BB/CD137 Antibody (3H3)  Chemical Structure
  27. GC66337 Anti-Mouse PD-L1 Antibody Anti-Mouse PD-L1 Antibody (10F.9G2) is an IgG2b antibody inhibitor against mouse PD-L1 (CD274/B7-H1), and the host is rat (Rat). Anti-Mouse PD-L1 Antibody  Chemical Structure
  28. GC35361 Antineoplaston A10 Antineoplaston A10, a naturally occurring substance in human body, is a Ras inhibitor potentially for the treatment of glioma, lymphoma, astrocytoma and breast cancer. Antineoplaston A10  Chemical Structure
  29. GC71544 Antroquinonol Antroquinonol ((+)-Antroquinonol), a ubiquinone derivative from the mushroom Antrodia camphorata, has hepatoprotective, anti-inflammatory, and anti-cancer effects. Antroquinonol  Chemical Structure
  30. GC91176 AOH1996

    An inhibitor of PCNA

    AOH1996  Chemical Structure
  31. GC91040 AP-1

    A PROTAC that drives ALK degradation

    AP-1  Chemical Structure
  32. GC34172 AP1867 AP1867 is a synthetic FKBP12F36V-directed ligand. AP1867  Chemical Structure
  33. GC61745 AP1867-2-(carboxymethoxy)

    PROTAC FKBP12-binding moiety 2

    AP1867-2-(carboxymethoxy), the AP1867 (a synthetic FKBP12F36V-directed ligand) based moiety, binds to CRBN ligand via a linker to form dTAG molecules. AP1867-2-(carboxymethoxy)  Chemical Structure
  34. GC15586 AP1903

    AP1903

    AP1903 (AP1903) is a dimerizer agent that acts by cross-linking the FKBP domains. AP1903 (AP1903) dimerizes the Caspase 9 suicide switch and rapidly induces apoptosis. AP1903  Chemical Structure
  35. GC14498 AP20187

    B/B Homodimerizer

    Dimerizer,synthetic and cell-permeable AP20187  Chemical Structure
  36. GC18518 Apcin Apcin is an inhibitor of the E3 ligase activity of the mitotic anaphase-promoting complex/cyclosome (APC/C). Apcin  Chemical Structure
  37. GC62419 Apcin-A Apcin-A, an Apcin derivative, is an anaphase-promoting complex (APC) inhibitor. Apcin-A interacts strongly with Cdc20, and inhibits the ubiquitination of Cdc20 substrates. Apcin-A can be used to synthesize the PROTAC CP5V. Apcin-A  Chemical Structure
  38. GC35367 APG-115

    AA-115

    APG-115 (APG-115) is an orally active MDM2 protein inhibitor binding to MDM2 protein with IC50 and Ki values of 3.8 nM and 1 nM, respectively. APG-115 blocks the interaction of MDM2 and p53 and induces cell-cycle arrest and apoptosis in a p53-dependent manner. APG-115  Chemical Structure
  39. GC62640 APG-1387 APG-1387, a bivalent SMAC mimetic and an IAP antagonist, blocks the activity of IAPs family proteins (XIAP, cIAP-1, cIAP-2, and ML-IAP). APG-1387 induces degradation of cIAP-1 and XIAP proteins, as well as caspase-3 activation and PARP cleavage, which leads to apoptosis. APG-1387 can be used for the research of hepatocellular carcinoma, ovarian cancer, and nasopharyngeal carcinoma. APG-1387  Chemical Structure
  40. GC12961 Apicidin

    OSI 2040

    A cell-permeable HDAC inhibitor

    Apicidin  Chemical Structure
  41. GC46862 Apigenin-d5

    3,6,8,3’,5’-d5-Apigenin, Chamomile-d5, Flavone-d5, Versulin-d5

    An internal standard for the quantification of apigenin Apigenin-d5  Chemical Structure
  42. GC16237 Apocynin

    Acetoguaiacone, Acetovanillone, NSC 2146, NSC 209524

    Selective NADPH-oxidase inhibitor Apocynin  Chemical Structure
  43. GC14080 Apogossypolone (ApoG2)

    ApoG2

    Apogossypolone (ApoG2)  Chemical Structure
  44. GC74102 Apomine

    SR-45023A; SR 9223i; SK&F-99085

    Apomine (SR-45023A) is an antineoplastic agent that inhibits the mevalonate/isoprenoid pathway in cholesterol synthesis. Apomine  Chemical Structure
  45. GC42827 Apoptolidin

    Apoptolidin A

    Apoptolidin is an apoptosis inducer originally isolated from Nocardiopsis bacteria. Apoptolidin  Chemical Structure
  46. GC14209 Apoptosis Activator 2

    AAII, N-(3,4-dichlorobenzyl) Isatin

    An activator of caspases Apoptosis Activator 2  Chemical Structure
  47. GC14411 Apoptozole

    Apoptosis Activator VII

    inhibitor of heat shock protein 70 (Hsp70) Apoptozole  Chemical Structure
  48. GC65004 Apostatin-1

    Apt-1

    Apostatin-1 (Apt-1) is a potent TRADD inhibitor. Apostatin-1  Chemical Structure
  49. GC35377 Apratastat

    TMI-005

    An inhibitor of ADAM17 and MMPs Apratastat  Chemical Structure
  50. GC10420 Apremilast (CC-10004)

    APR, CC-10004

    An orally available PDE4 inhibitor Apremilast (CC-10004)  Chemical Structure
  51. GC32692 APTO-253 (LOR-253)

    APTO-253

    APTO-253 is a novel small molecule that exerts potent antitumor activity by inducing Kruppel-like factor 4(KLF4) master transcription factor gene expression, thereby inhibiting cell cycle and leading to programmed cell death. APTO-253 (LOR-253)  Chemical Structure
  52. GC70759 AQX-435 AQX-435 is a potent SHIP1 phosphatase activator. AQX-435  Chemical Structure
  53. GC14590 AR-42 (OSU-HDAC42)

    HDAC inhibitor,novel and potent

    AR-42 (OSU-HDAC42)  Chemical Structure
  54. GC45385 Ara-G

    ara-Guanosine, Guanine Arabinoside, NSC 76352

      Ara-G  Chemical Structure
  55. GC46878 Aranciamycin

    NSC 369226

    A fungal metabolite with diverse biological activities Aranciamycin  Chemical Structure
  56. GC40116 Aranorosin Aranorosin is a fungal metabolite originally isolated from P. Aranorosin  Chemical Structure
  57. GC65163 Ardisiacrispin B Ardisiacrispin B displays cytotoxic effects in multi-factorial drug resistant cancer cells via ferroptotic and apoptotic cell death. Ardisiacrispin B  Chemical Structure
  58. GC49314 Arecaidine propargyl ester (hydrobromide)

    APE

    A muscarinic M2 agonist Arecaidine propargyl ester (hydrobromide)  Chemical Structure
  59. GC73077 ARI-1 ARI-1 is an inhibitor of receptor tyrosine kinase-like orphan receptor 1 (ROR1) inhibitor. ARI-1  Chemical Structure
  60. GC35388 Aristolactam I Aristololactam I (AL-I), is the main metabolite of aristolochic acid I (AA-I), participates in the processes that lead to renal damage. Aristolactam I  Chemical Structure
  61. GC35395 Arnicolide D

    ARD

    Arnicolide D is a sesquiterpene lactone isolated from Centipeda minima. Arnicolide D modulates the cell cycle, activates the caspase signaling pathway and inhibits the PI3K/AKT/mTOR and STAT3 signaling pathways. Arnicolide D inhibits Nasopharyngeal carcinoma (NPC) cell viability in a concentration- and time-dependent manner. Arnicolide D  Chemical Structure
  62. GC60601 ARRY-382 ARRY-382  Chemical Structure
  63. GC19037 ARS-853 ARS-853 is a selective, covalent KRASG12C inhibitor with an IC50 of 2.5 uM. ARS-853  Chemical Structure
  64. GC46882 Artemisinin-d3

    Qinghaosu-d3; NSC 369397-d3

    An internal standard for the quantification of artemisinin Artemisinin-d3  Chemical Structure
  65. GC10040 Arylquin 1 potent secretagogue of the tumor suppressor protein prostate apoptosis response-4 (Par-4) Arylquin 1  Chemical Structure
  66. GC62615 AS-99 AS-99 is a first-in-class, potent and selective ASH1L histone methyltransferase inhibitor (IC50=0.79μM, Kd=0.89μM) with anti-leukemic activity. AS-99 blocks cell proliferation, induces apoptosis and differentiation, downregulates MLL fusion target genes, and reduces the leukemia burden in vivo. AS-99  Chemical Structure
  67. GC74719 ASC-69

    APY69

    ASC-69 (APY69)is a potent and promising PD-1/PD-L1 small-molecule inhibitor. ASC-69  Chemical Structure
  68. GC40715 Ascochlorin

    Antibiotic LL-Z1272γ, Ilicicolin D, NSC 287492

    Ascochlorin is an isoprenoid antibiotic and antiviral that has diverse effects on mammalian cells. Ascochlorin  Chemical Structure
  69. GC13215 Ascomycin(FK 520)

    Changchuanmycin, FK-520, FR900520, Immunomycin, L 683590

    A potent macrolide immunosuppressant Ascomycin(FK 520)  Chemical Structure
  70. GC12070 Ascorbic acid (Standard)

    Ascorbate, NSC 33832, NSC 218455, Vitamin C

    An electron donor Ascorbic acid (Standard)  Chemical Structure
  71. GC74029 ASCT2-IN-1 ASCT2-IN-1 (compound 20k) is an ASCT2 inhibitor with IC50 values of 5.6 μM and 3.5 μM in cells A549 and HEK293, respectively. ASCT2-IN-1  Chemical Structure
  72. GC74030 ASCT2-IN-2 ASCT2-IN-2 (compound 25e) is an ASCT2 inhibitor with IC50 of 5.14 μM. ASCT2-IN-2  Chemical Structure
  73. GN10702 Asiatic acid

    Dammarolic Acid, NSC 166063

    Asiatic acid  Chemical Structure
  74. GN10534 Asiaticoside

    Ba 2742, NSC 36002, NSC 166062

    Asiaticoside  Chemical Structure
  75. GC19041 ASK1-IN-1 ASK1-IN-1 is a potent, orally available and selective ATP-competitive inhibitor of apoptosis signal-regulating kinase 1 (ASK1) with an IC50 of 2.87 nM. ASK1-IN-1  Chemical Structure
  76. GC62426 ASK1-IN-2 ASK1-IN-2 is a potent and orally active inhibitor of apoptosis signal-regulating kinase 1 (ASK1), with an IC50 of 32.8 nM. ASK1-IN-2  Chemical Structure
  77. GC71258 ASK1-IN-4 ASK1-IN-4 (Compound 17) is an ASK1 inhibitor (IC50=0.2 μM). ASK1-IN-4  Chemical Structure
  78. GC42858 Aspergillin PZ Aspergillin PZ is a fungal metabolite originally isolated from A. Aspergillin PZ  Chemical Structure
  79. GC60603 Asperosaponin VI

    Akebia Saponin D, ASA VI, Leiyemudanoside A, Tauroside St-G0-1

    A triterpenoid saponin with diverse biological activities Asperosaponin VI  Chemical Structure
  80. GC72803 Aspidin BB Aspidin BB is a phloroglucinol derivative, which can be isolated from the aerial part of Dryopteris championii. Aspidin BB  Chemical Structure
  81. GC42860 Aspochalasin D Aspochalasin D is a co-metabolite originally isolated from A. Aspochalasin D  Chemical Structure
  82. GC68700 ASR-488

    ASR-488 can activate mRNA binding protein CPEB1, induce apoptosis and inhibit the growth of bladder cancer cells.

    ASR-488  Chemical Structure
  83. GC41640 Asterriquinol D dimethyl ether Asterriquinol D dimethyl ether is a fungal metabolite that has been found in A. Asterriquinol D dimethyl ether  Chemical Structure
  84. GN10415 Astilbin

    Taxifolin 3-O-rhamnoside

    Astilbin  Chemical Structure
  85. GN10561 astragalin

    Astragalin, Kaempferol 3-β-D-glucopyranoside

    astragalin  Chemical Structure
  86. GC18109 Astragaloside A

    AS-A, AST-A, Astramembrannin I

    Astragaloside A is an active saponin compound extracted from Astragalus membranaceus with antioxidant, cardioprotective, anti-inflammatory, antiviral, antibacterial, antifibrosis, antidiabetic and immunomodulatory pharmacological effects. Astragaloside A  Chemical Structure
  87. GC35415 Astramembrangenin Astramembrangenin  Chemical Structure
  88. GC32803 ASTX660

    Tolinapant

    ASTX660 is an orally bioavailable dual antagonist of cellular inhibitor of apoptosis protein (cIAP) and X-linked inhibitor of apoptosis protein (XIAP). ASTX660  Chemical Structure
  89. GC42863 Asukamycin

    AM1042, Asukamycin A

    Asukamycin is polyketide isolated from the S. Asukamycin  Chemical Structure
  90. GC74507 Asunercept

    APG101; CAN008

    Asunercept (APG101; CAN008) is a soluble CD95-Fc fusion protein targeting CD95L. Asunercept  Chemical Structure
  91. GC11106 AT-101 AT-101  Chemical Structure
  92. GC17448 AT-406 (SM-406)

    SM-406

    AT-406 (SM-406) (AT-406) is a potent and orally bioavailable Smac mimetic and an antagonist of IAPs, and it binds to XIAP, cIAP1, and cIAP2 proteins with Ki of 66.4, 1.9, and 5.1 nM, respectively. AT-406 (SM-406)  Chemical Structure
  93. GC15870 AT7519 Multi-CDK inhibitor AT7519  Chemical Structure
  94. GC13998 AT7519 Hydrochloride A Cdk inhibitor AT7519 Hydrochloride  Chemical Structure
  95. GC10638 AT9283 A broad spectrum kinase inhibitor AT9283  Chemical Structure
  96. GC18133 ATB-346

    ATB-346

    ATB-346 (ATB-346), an orally active non-steroidal anti-inflammatory drug (NSAID), inhibits cyclooxygenase-1 and 2 (COX-1 and 2). ATB-346  Chemical Structure
  97. GC32704 Atezolizumab (MPDL3280A) Atezolizumab, a specific monoclonal antibody against PD-L1, can inhibit the combination between PD-L1 and PD-1. Atezolizumab (MPDL3280A)  Chemical Structure
  98. GC62499 ATH686 ATH686 is a potent, selective and ATP-competitive FLT3 inhibitor. ATH686 target mutant FLT3 protein kinase activity and inhibit the proliferation of cells harboring FLT3 mutants via induction of apoptosis and cell cycle inhibition. ATH686 has antileukemic effects. ATH686  Chemical Structure
  99. GC73939 ATPase-IN-3 ATPase-IN-3 (compound 6) is a ATPase inhibitor. ATPase-IN-3  Chemical Structure
  100. GC46892 ATRA-BA Hybrid A prodrug form of all-trans retinoic acid and butyric acid ATRA-BA Hybrid  Chemical Structure
  101. GN10394 Atractylenolide III

    Atractylenolide β, Codonolactone

    Atractylenolide III  Chemical Structure

Items 301 to 400 of 2711 total

per page
  1. 2
  2. 3
  3. 4
  4. 5
  5. 6

Set Descending Direction